AT-007 T10393
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
AT-007 is an orally active CNS penetrant Aldose Reductase inhibitor for the treatment of Galactosemia (IC50: 100 pM). It reduces toxic galactitol levels and prevents disease complications in GALT deficiency rats.
CAS nr:
2170729-29-8
Purity:
98%
Molecular Weight:
425,4
SMILES:
OC(CC(c1cscc11)=NN(Cc2nc(cc(C(F)(F)F)cc3)c3s2)C1=O)=O
Formula:
C17H10F3N3O3S2
Pathway:
Metabolism,Endocrinology/Hormones
Target:
Reductase,Reductase
